Neuropharmacological therapy of carcinoid syndrome.
Fuad
F
Lechin
Bertha
B
van der Dijs
D000311:Adrenal Glands / Q000503:physiopathology; D018663:Adrenergic Agents / Q000627:therapeutic use*; D002490:Central Nervous System / Q000187:drug effects* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology*; D009638:Norepinephrine / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D016896:Treatment Outcome
D018663:Adrenergic Agents; D012701:Serotonin; D009638:Norepinephrine